Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,460 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Completed

E-MOSAIC Electronic Tool to Monitor Symptoms

NCT00477919

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +115 more
Locations
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Spital Buelach Bülach, Switzerland
View Trial Details
Completed

Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

NCT00030732

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Allgemeines Krankenhaus der Stadt Wien Vienna, Austria
  • Tel-Aviv Sourasky Medical Center Tel Aviv, Israel
  • Istituto Nazionale per lo Studio e la Cura dei Tumori Milan, Italy
  • Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy
View all 18 locations
View Trial Details
Completed

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

NCT00219557

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
Locations
  • East Bay Medical Oncology/Hematology Medical Associates Inc. Antioch, California, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • Bay Area Cancer Research Group Concord, California, United States
  • East Bay Medical Oncology/Hematology Medical Associates, Inc. Concord, California, United States
View all 38 locations
View Trial Details
Completed

Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas

NCT01088815

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations
  • Translational Genomics Research Institute (TGen) Scottsdale, Arizona, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas

NCT01188785

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • Shaare Zedek Medical Center Jerusalem, Israel
  • Hadassah Medical Organization Jerusalem, Israel
  • Sheba Medical Center Ramat Gan, Israel
View Trial Details
Completed

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

NCT00735917

Conditions
Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado at Denver Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions